TABLE 4

Frequency of chronic pulmonary aspergillosis (CPA)

All patientsHIV-positiveHIV-negativep-value
Subjects285135150
CCPA10 (3.5 (1.8–6.1))2 (1.5 (0.3–4.7))8 (5.3 (2.6–9.8))0.108
CFPA3 (1.1 (0.3–2.8))1 (0.7 (0.1–3.4))2 (1.3 (0.3–4.2))1
Simple aspergilloma1 (0.4 (0–1.6))1 (0.7 (0.1–3.4))0 (0 (0–1.7))0.474
All definite CPA14 (4.9 (2.8–7.9))4 (3.0 (1–6.9))10 (6.7 (3.5–11.5))0.177
Seronegative fungal ball2 (0.7 (0.1–2.2))1 (0.7 (0.1–3.4))1 (0.7 (0.1–3.1))1
Probable CPA in non-CT group2 (0.7 (0.1–2.2))2 (1.5 (0.3–4.7))0 (0 (0–1.7))0.223
All definite and probable CPA18 (6.3 (3.9–9.6))7 (5.2 (2.3–9.9))11 (7.3 (4–12.3))0.478

Data are presented as n or n (% (95% CI)), unless otherwise stated. CCPA: chronic cavitary pulmonary aspergillosis; CFPA: chronic fibrosing pulmonary aspergillosis; CT: computed tomography. All p-values calculated by Fisher's exact test. p<0.05 considered significant.